Nautilus Biotechnology
Price & Volume
Stats
See more52W Range | $0.62-$2.54 |
Market Cap | $282.9M |
Shares Short | 184,156 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.50 |
News
See moreYahoo Finance • 26 days ago
Nautilus (NAUT) Q3 2025 Earnings Call Transcript
Yahoo Finance • 4 months ago
Nautilus Biotechnology Reports Second Quarter 2025 Financial Results
Yahoo Finance • 3 years ago
Nautilus Biotechnology to Participate in B. Riley Securities’ Disruptive Biotech Enabling Technologies – Proteomics, Virtual Conference
Yahoo Finance • 3 years ago
Nautilus Biotechnology to Announce Second Quarter 2022 Financial Results on August 2, 2022
About
CEO | Mr. Sujal M. Patel |
CFO | Ms. Anna Mowry |
Address | 2701 Eastlake Avenue East, Seattle, WA, United States, 98102 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 124 |
